Companies previously delayed vaccine programme after Phase I/II study results found a low immune response in older adults
News
PharmaTimes are proud to confirm the launch of the 2021 Sales Awards
The 2021 Sales Awards have opened their doors for entry, continuing its legacy of uncovering and rewarding exceptional talent within the pharma sales sector.
Remove barriers restricting the research of controlled drugs, says RPS
Comments come in response to a consultation from the Advisory Council on the Misuse of Drugs
Alzheimer’s drug designed using Exscientia’s AI technology enters clinic
Drug candidate is being evaluated for the treatment of Alzheimer’s disease psychosis
NICE nod for BMS’ Opdivo in advanced oesophageal cancer
Cost-effectiveness watchdog recommends first immunotherapy for unresectable advanced oesophageal cancer
GSK, CureVac’s next-gen COVID-19 jab generates positive preclinical data
Vaccine induced strong immune responses in a rat model during preclinical testing
Abbott’s AI-powered coronary imaging platform deployed in the UK
Heart attack patients offered treatment with new technology at the Royal Free Hospital in London
Novo Nordisk’s weight loss drug semaglutide found to improve wellbeing
New results from a Phase IIIa study demonstrate benefits of drug for people with obesity ‘beyond weight loss’
Pfizer enrols first UK participant into global DMD gene therapy study
The CIFFREO study is expected to enrol 99 ambulatory male patients aged four to seven years old
NHS injects $160m into ‘elective accelerators’ to combat waiting lists
Accelerator sites will introduce new and ‘innovative’ ways of working to accelerate elective recovery
Astellas’ Xtandi bags additional MHRA approval in prostate cancer
Once-daily oral Xtandi approved for the treatment of adult men with metastatic hormone-sensitive prostate cancer
Huma completes $130m funding round to expand digital ‘hospitals at home’ platform
UK healthtech company is now planning to expand platform in the US, Asia and the Middle East
NICE rejects Pfizer’s rare heart disease treatment Vyndaqel
The final guidance publication comes following an appeal against earlier draft recommendations
New NHS legislation provides ‘once-in-a-decade opportunity’ to centre research
Pharma industry and health leaders react to new legislation and plans outlined in the Queen’s Speech
MHRA approves label extension for Vertex’s Kaftrio combo
Extension of indication expands access to drug for additional cystic fibrosis patients in Great Britain
